Exponent, Inc. (NASDAQ:EXPO – Get Free Report) VP Joseph Rakow sold 2,945 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $54.66, for a total transaction of $160,973.70. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
Exponent Trading Up 0.2%
NASDAQ:EXPO opened at $53.79 on Friday. Exponent, Inc. has a 1 year low of $51.91 and a 1 year high of $81.95. The firm has a 50 day moving average of $65.71 and a 200-day moving average of $69.74. The stock has a market capitalization of $2.61 billion, a P/E ratio of 25.02 and a beta of 0.78.
Exponent (NASDAQ:EXPO – Get Free Report) last posted its earnings results on Thursday, April 30th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.03. The company had revenue of $166.30 million during the quarter, compared to analysts’ expectations of $149.53 million. Exponent had a net margin of 18.07% and a return on equity of 27.94%. Exponent’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 earnings per share. As a group, analysts forecast that Exponent, Inc. will post 2.28 EPS for the current fiscal year.
Exponent Announces Dividend
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. UBS Group lowered their price target on shares of Exponent from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, May 1st. Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Tuesday, April 21st. Finally, JPMorgan Chase & Co. lowered their price target on shares of Exponent from $95.00 to $80.00 and set an “overweight” rating for the company in a report on Friday. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $77.50.
Read Our Latest Research Report on EXPO
Institutional Trading of Exponent
Hedge funds and other institutional investors have recently modified their holdings of the stock. Bell Investment Advisors Inc grew its holdings in Exponent by 423.6% during the 1st quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider’s stock worth $25,000 after acquiring an additional 305 shares during the period. Hantz Financial Services Inc. grew its holdings in Exponent by 97.0% during the 3rd quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock worth $28,000 after acquiring an additional 195 shares during the period. Aster Capital Management DIFC Ltd bought a new position in shares of Exponent during the third quarter worth $33,000. Allworth Financial LP boosted its position in shares of Exponent by 86.1% during the fourth quarter. Allworth Financial LP now owns 469 shares of the business services provider’s stock worth $33,000 after purchasing an additional 217 shares in the last quarter. Finally, Winnow Wealth LLC bought a new position in shares of Exponent during the third quarter worth $34,000. Institutional investors and hedge funds own 92.37% of the company’s stock.
Exponent Company Profile
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Featured Stories
- Five stocks we like better than Exponent
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
